Our study designed to show that targeting autophagy withsynergistic combination of BMP4 and LTL caused morphological and molecular changes(Beclin-1, LC3 II, and p62) leading to disparate levels of growth inhibition due todissimilar status of the tumor suppressor p53 in the glioblastoma cell lines. The gene discussed is TP53; the disease is glioblastoma.